More articles from Volume 47, Issue 1, 2018
The effect of morphine on development of ulcer lesions of the rats exposed to indomethacin induced stress
Sleep habits of students
Direct and indirect pulp capping using glass-ionomer cement
The importance and role of echotomographic examinations in malignant altered axillary lymph nodes
Histological analysis of tissue of the interdental space before and after correction of irregular fillings: Experimenting on animals
Concentrations of sodium 3α, 7α--dihydroxy-12-oxo 5β cholanate in biological material after its intravenous and intranasal application
,
Snežana Stević
,
Momir Mikov
,
Zorica Stanojević-Ristić
,
Julijana Rašić
Leonida Vitković
Abstract
References
1.
Zimber A, Gespach C. Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential. Vol. 8, Anti-Cancer Agents in Medicinal Chemistry. 2008. p. 540–63.
2.
R CG. Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial. Vol. 204. 2004. p. 632–5.
3.
Shinichiro H, Takatsuka Y, Hiroyuki M. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Vol. 9, International Journal of Pharmaceutics. 1981. p. 173–84.
4.
Cravotto G, Boffa L, Turello M, Parenti M, Barge A. Chemical modifications of bile acids under high-intensity ultrasound or microwave irradiation. Vol. 70, Steroids. 2005. p. 77–83.
5.
Russell DW. The Enzymes, Regulation, and Genetics of Bile Acid Synthesis. Vol. 72, Annual Review of Biochemistry. 2003. p. 137–74.
6.
Sheltawy MJ, Losowsky MS. Determination of faecal bile acids by an enzymic method. Vol. 64, Clinica Chimica Acta. 1975. p. 127–32.
7.
Sobotka H, Bloch E. The Steroids. Vol. 12, Annual Review of Biochemistry. 1943. p. 45–80.
8.
Kuhajda K, Kantrač J, Mikov M, ur. Biosinteza žučnih kiselina u jetri sisara. Žučne kiseline, određivanje, hemijske transformacije, farmakološko dejstvo. 1999.
9.
Stević S, Stajić D, Stanojević Z, Bukumirić Z, Mikov M, Kuhajda K, et al. Intranasal application of bile acids and insulin can affect blood glucose levels in rats. Vol. 8. 2009. p. 87–91.
10.
Mikov M, Boni NS, Al-Salami H, Kuhajda K, Kevresan S, Golocorbin-Kon S, et al. Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3α,7α-dihydroxy-12-0X0-5β-cholanate, in healthy and diabetic rats. Vol. 32, European Journal of Drug Metabolism and Pharmacokinetics. 2007. p. 7–12.
11.
Mikov M, Fawcett JP, Kuhajda K, Kevresan S. Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents. Vol. 31, European Journal of Drug Metabolism and Pharmacokinetics. 2006. p. 237–51.
12.
Baščarević S, Vasović V, Mikov M, Kuhajda K, Kevrešan S. Salicylates transport into the rat brain under the influence of monoketocholic acid. Vol. 590. 1998.
13.
Chein YW, Su KS, Chang SF. Nasal systemic drug delivery. 1989.
14.
Kissel T, Werner U. Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium. Vol. 53, Journal of Controlled Release. 1998. p. 195–203.
15.
HOSOYA K, KUBO H, NATSUME H, SUGIBAYASHI K, MORIMOTO Y. Evaluation of Enhancers to Increase Nasal Absorption Using Ussing Chamber Technique. Vol. 17, Biological and Pharmaceutical Bulletin. 1994. p. 316–22.
16.
Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC. Intranasal delivery: Physicochemical and therapeutic aspects. Vol. 337, International Journal of Pharmaceutics. 2007. p. 1–24.
17.
Chien YW. Transnasal Systemic Medications. 1985.
18.
Talegonkar S, Mishra PR. Intranasal delivery: An approach to by pass the blood brain barrier. Vol. 36. 2004. p. 140–7.
19.
Meaney CM, O’Driscoll CM. A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model. Vol. 207, International Journal of Pharmaceutics. 2000. p. 21–30.
20.
Mälkiä A, Murtomäki L, Urtti A, Kontturi K. Drug permeation in biomembranes. Vol. 23, European Journal of Pharmaceutical Sciences. 2004. p. 13–47.
21.
Coca E, Ribas B, Trigueros G, Sarmiento JM, Borque M, Ortega D, et al. A Method for Quick Determination of Bile Acids in Bile of Patients with Biliary Lithiasis. Vol. 17, Journal of Liquid Chromatography. 1994. p. 1349–63.
22.
Jones ML, Chen H, Ouyang W, Metz T, Prakash S. Method for bile acid determination by high performance liquid chromatography. Vol. 23. 2003. p. 277–80.
23.
Kuhajda K, Kevresan S, Kandrac J, Fawcett JP, Mikov M. Chemical and metabolic transformations of selected bile acids. Vol. 31, European Journal of Drug Metabolism and Pharmacokinetics. 2006. p. 179–235.
24.
Gordon GS, Moses AC, Silver RD, Flier JS, Carey MC. Nasal absorption of insulin: enhancement by hydrophobic bile salts. Vol. 82, Proceedings of the National Academy of Sciences. 1985. p. 7419–23.
25.
Mithani SD, Bakatselou V, TenHoor CN, Dressman JB. Vol. 13, Pharmaceutical Research. 1996. p. 163–7.
26.
Kushwaha KS, Keshari RK, Rai AK. Advances in nasal trans-mucosal drug delivery. Vol. 01. 2011. p. 21–8.
27.
Liu X, Testa B, Fahr A. Lipophilicity and Its Relationship with Passive Drug Permeation. Vol. 28, Pharmaceutical Research. 2011. p. 962–77.
28.
Yang L, Zhang H, Fawcett JP, Mikov M, Tucker IG. Effect of Bile Salts on the Transport of Morphine-6-Glucuronide in Rat Brain Endothelial Cells. Vol. 100, Journal of Pharmaceutical Sciences. 2011. p. 1516–24.
29.
Al-Salami, H., Butt, G., Tucker, I., Mikov, M. Influence of the semisynthetic bile acid MKC on the ileal
permeation of gliclazide in vitro in healthy and diabetic rats
treated with probiotics. Vol. 30, Methods and Findings in Experimental and Clinical Pharmacology. p. 107.
30.
Yang L, Zhang H, Mikov M, Tucker IG. Physicochemical and Biological Characterization of Monoketocholic Acid, a Novel Permeability Enhancer. Vol. 6, Molecular Pharmaceutics. 2009. p. 448–56.
31.
Kuhajda K, Cvjeticanin S, Djurendic E, Sakac M, Penov-Gasi K, Kojic V, et al. Synthesis and cytotoxic activity of a series of bile acid derivatives. Vol. 63, Chemical Industry. 2009. p. 313–8.
32.
Rodrigues CM, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. Vol. 101, Journal of Clinical Investigation. 1998. p. 2790–9.
33.
Kim ND, Im EO, Choi YH, Yoo YH. Synthetic Bile Acids: Novel Mediators of Apoptosis. Vol. 35, BMB Reports. 2002. p. 134–41.
34.
Carubbi F, Guicciardi ME, Concari M, Loria P, Bertolotti M, Carulli N. Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. Vol. 1580, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2002. p. 31–9.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
